127 related articles for article (PubMed ID: 31690033)
41. Cyano Enone-Bearing Triterpenoid Soloxolone Methyl Inhibits Epithelial-Mesenchymal Transition of Human Lung Adenocarcinoma Cells In Vitro and Metastasis of Murine Melanoma In Vivo.
Markov AV; Odarenko KV; Sen'kova AV; Salomatina OV; Salakhutdinov NF; Zenkova MA
Molecules; 2020 Dec; 25(24):. PubMed ID: 33327637
[TBL] [Abstract][Full Text] [Related]
42. Agonist anti-GITR monoclonal antibody induces melanoma tumor immunity in mice by altering regulatory T cell stability and intra-tumor accumulation.
Cohen AD; Schaer DA; Liu C; Li Y; Hirschhorn-Cymmerman D; Kim SC; Diab A; Rizzuto G; Duan F; Perales MA; Merghoub T; Houghton AN; Wolchok JD
PLoS One; 2010 May; 5(5):e10436. PubMed ID: 20454651
[TBL] [Abstract][Full Text] [Related]
43. Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-β.
Lv C; Dai H; Sun M; Zhao H; Wu K; Zhu J; Wang Y; Cao X; Xia Z; Xue C
Melanoma Res; 2017 Apr; 27(2):74-84. PubMed ID: 28079609
[TBL] [Abstract][Full Text] [Related]
44. Human Gastric Cancer Mesenchymal Stem Cell-Derived IL15 Contributes to Tumor Cell Epithelial-Mesenchymal Transition via Upregulation Tregs Ratio and PD-1 Expression in CD4
Sun L; Wang Q; Chen B; Zhao Y; Shen B; Wang X; Zhu M; Li Z; Zhao X; Xu C; Chen Z; Wang M; Xu W; Zhu W
Stem Cells Dev; 2018 Sep; 27(17):1203-1214. PubMed ID: 29901436
[TBL] [Abstract][Full Text] [Related]
45. Suppression of antitumor immunity by IL-10 and TGF-beta-producing T cells infiltrating the growing tumor: influence of tumor environment on the induction of CD4+ and CD8+ regulatory T cells.
Jarnicki AG; Lysaght J; Todryk S; Mills KH
J Immunol; 2006 Jul; 177(2):896-904. PubMed ID: 16818744
[TBL] [Abstract][Full Text] [Related]
46. Tumor-infiltrating human CD4
Ahmadzadeh M; Pasetto A; Jia L; Deniger DC; Stevanović S; Robbins PF; Rosenberg SA
Sci Immunol; 2019 Jan; 4(31):. PubMed ID: 30635355
[TBL] [Abstract][Full Text] [Related]
47. Epidemiological trends in skin cancer.
Apalla Z; Lallas A; Sotiriou E; Lazaridou E; Ioannides D
Dermatol Pract Concept; 2017 Apr; 7(2):1-6. PubMed ID: 28515985
[TBL] [Abstract][Full Text] [Related]
48. Mechanisms of Drug Resistance in Melanoma.
Winder M; Virós A
Handb Exp Pharmacol; 2018; 249():91-108. PubMed ID: 28275910
[TBL] [Abstract][Full Text] [Related]
49. Towards therapeutic advances in melanoma management: An overview.
Singh S; Zafar A; Khan S; Naseem I
Life Sci; 2017 Apr; 174():50-58. PubMed ID: 28238718
[TBL] [Abstract][Full Text] [Related]
50. SPAG6 and L1TD1 are transcriptionally regulated by DNA methylation in non-small cell lung cancers.
Altenberger C; Heller G; Ziegler B; Tomasich E; Marhold M; Topakian T; Müllauer L; Heffeter P; Lang G; End-Pfützenreuter A; Döme B; Arns BM; Klepetko W; Zielinski CC; Zöchbauer-Müller S
Mol Cancer; 2017 Jan; 16(1):1. PubMed ID: 28093071
[TBL] [Abstract][Full Text] [Related]
51. Oncolytic adenovirus coexpressing interleukin-12 and decorin overcomes Treg-mediated immunosuppression inducing potent antitumor effects in a weakly immunogenic tumor model.
Oh E; Choi IK; Hong J; Yun CO
Oncotarget; 2017 Jan; 8(3):4730-4746. PubMed ID: 28002796
[TBL] [Abstract][Full Text] [Related]
52. Overexpression of the transcription factor FOXP3 in lung adenocarcinoma sustains malignant character by promoting G1/S transition gene CCND1.
Li Y; Li D; Yang W; Fu H; Liu Y; Li Y
Tumour Biol; 2016 Jun; 37(6):7395-404. PubMed ID: 26676638
[TBL] [Abstract][Full Text] [Related]
53. Roles of Foxp3 in the occurrence and development of cervical cancer.
Luo Q; Zhang S; Wei H; Pang X; Zhang H
Int J Clin Exp Pathol; 2015; 8(8):8717-30. PubMed ID: 26464616
[TBL] [Abstract][Full Text] [Related]
54. Inhibition of Foxp3 in cancer cells induces apoptosis of thyroid cancer cells.
Chu R; Liu SY; Vlantis AC; van Hasselt CA; Ng EK; Fan MD; Ng SK; Chan AB; Du J; Wei W; Liu X; Liu Z; Chen GG
Mol Cell Endocrinol; 2015 Jan; 399():228-34. PubMed ID: 25312920
[TBL] [Abstract][Full Text] [Related]
55. Increased expression of Slug and Vimentin as novel predictive biomarkers for lymph node metastasis and poor prognosis in colorectal cancer.
Toiyama Y; Yasuda H; Saigusa S; Tanaka K; Inoue Y; Goel A; Kusunoki M
Carcinogenesis; 2013 Nov; 34(11):2548-57. PubMed ID: 24001454
[TBL] [Abstract][Full Text] [Related]
56. Activation of AKT signaling promotes epithelial-mesenchymal transition and tumor growth in colorectal cancer cells.
Suman S; Kurisetty V; Das TP; Vadodkar A; Ramos G; Lakshmanaswamy R; Damodaran C
Mol Carcinog; 2014 Feb; 53 Suppl 1():E151-60. PubMed ID: 24000138
[TBL] [Abstract][Full Text] [Related]
57. Oncolytic adenovirus expressing IL-23 and p35 elicits IFN-γ- and TNF-α-co-producing T cell-mediated antitumor immunity.
Choi IK; Li Y; Oh E; Kim J; Yun CO
PLoS One; 2013; 8(7):e67512. PubMed ID: 23844018
[TBL] [Abstract][Full Text] [Related]
58. Targeted therapy for melanoma: rational combinatorial approaches.
Kwong LN; Davies MA
Oncogene; 2014 Jan; 33(1):1-9. PubMed ID: 23416974
[TBL] [Abstract][Full Text] [Related]
59. Tumor necrosis factor receptor 2-dependent homeostasis of regulatory T cells as a player in TNF-induced experimental metastasis.
Chopra M; Riedel SS; Biehl M; Krieger S; von Krosigk V; Bäuerlein CA; Brede C; Jordan Garrote AL; Kraus S; Schäfer V; Ritz M; Mattenheimer K; Degla A; Mottok A; Einsele H; Wajant H; Beilhack A
Carcinogenesis; 2013 Jun; 34(6):1296-303. PubMed ID: 23385062
[TBL] [Abstract][Full Text] [Related]
60. Forkhead box P3 regulatory T cells coexisting with cancer associated fibroblasts are correlated with a poor outcome in lung adenocarcinoma.
Kinoshita T; Ishii G; Hiraoka N; Hirayama S; Yamauchi C; Aokage K; Hishida T; Yoshida J; Nagai K; Ochiai A
Cancer Sci; 2013 Apr; 104(4):409-15. PubMed ID: 23305175
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
